Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
California Department of Public Health
ClinicalTrials.gov Identifier:
NCT01701999
First received: October 3, 2012
Last updated: February 4, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)